Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 6INDUSTRY 5NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 2

Conditions

Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 1

Interventions

Cyclophosphamide 178Radiotherapy 147Paclitaxel 128Carboplatin 124Bevacizumab 123Cisplatin 119Doxorubicin 111Fluorouracil 107Etoposide 102Filgrastim 99Vincristine 88Leucovorin 82Bortezomib 80Gemcitabine 76aldesleukin 74Sorafenib 70Cytarabine 70Taxes 69fludarabine phosphate 67Irinotecan 66Docetaxel 64Oxaliplatin 60sargramostim 58Sirolimus 58temsirolimus 56Erlotinib Hydrochloride 56Methotrexate 55Rituximab 54Vorinostat 52Radiation 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × NIH × Homoharringtonine × Clear all
NCT00003694 2013-06-05

Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00002574 2013-02-05

Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
87 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Chronic-Phase

NCT00006364 2013-01-23

Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
50 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡